EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐Arthritic Potential of Pyrazoline Derivative Against Complete Freund's Adjuvant Induced Arthritis in Rats

Jian Li, Irfan Anjum, Halima Qadir iD, Faiza Naseer iD, Mehreen Arif, Muhammad Riaz, Rabia Gul, Madiha Kanwal iD, Bei Zhuang iD

Journal of Cellular and Molecular Medicine · 2026-02 · 30 (4)

DOI: 10.1111/jcmm.71030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 24.02.2026. Verfasst von Jian Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint and Sports Medicine, The Fourth People's Hospital of Jinan, Jinan, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Pyrazoles. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research explored the potential of a synthesised pyrazoline derivative 5‐ethoxy 5‐hydroxy 3‐methyls 4, 5‐dihydro 1Hpyrazol 1 yl (pyridine 4 yl) methanone [5‐E‐5‐H‐PD], against arthritis using a Complete Freund's Adjuvant (CFA)‐induced arthritis in a rat model. Sprague–Dawley rats were used to induce arthritis via subplantar injection of CFA (0.1 mL) into their right hind paw. Animals were divided into 6 groups ( n = 4): normal, arthritis, standard drug (methotrexate 1 mg/kg intraperitoneally), and 3 treatment groups receiving 5‐E‐5‐H‐PD, 10, 20 and 40 mg/kg orally for 21 days. Clinical signs (paw volume and arthritis score), pro‐inflammatory cytokines, and histopathological alterations were evaluated. The 5‐E‐5‐H‐PD groups showed a reduction in paw edema in a dose‐dependent manner. On day 21, paw volume in the 40 mg/kg dose animals decreased significantly to 2.31 ± 0.12 mm compared to 4.82 ± 0.14 mm in the disease animals ( p < 0.001). Arthritis scores reduced from 3.8 ± 0.2 (control) to 1.5 ± 0.3 in the high‐dose treatment group. Serum IL‐10, TNF‐α, and NF‐κB levels were significantly reduced to 66.75 ± 3.0 pg/mL, 34.50 ± 1.8 pg/mL and 9.50 ± 0.6 pg/mL respectively, compared to the arthritis induced rats 129.8 ± 2.0 pg/mL, 77.75 ± 1.5 pg/mL and 28.50 ± 1.3 pg/mL respectively, compared to the arthritis induced rats (112.3 ± 5.5, 96.8 ± 4.3, 123.1 ± 6.2 pg/mL, p < 0.001). Histopathology analysis confirmed reduced synovial hyperplasia and inflammatory infiltration in treated joints. The pyrazoline derivative, 5‐E‐5‐H‐PD, demonstrated significant anti‐arthritic effects in the CFA‐induced rat model by reducing inflammation, cytokine expression and joint destruction. These findings support further investigation into pyrazoline‐based compounds as promising therapeutic agents for RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalPyrazolesAnimalsFreund's AdjuvantRats, Sprague-DawleyRatsEdemaMaleCytokinesTumor Necrosis Factor-alphaAnti-Inflammatory Agents

Stichwörter der Autor:innen

arthritiscomplete Freund's adjuvant (CFA)paw edemaproinflammatory cytokinespyrazoline derivatives

Substanzen

Freund's AdjuvantPyrazolesCytokinesTumor Necrosis Factor-alphaAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Joint and Sports Medicine, The Fourth People's Hospital of Jinan, Jinan, China.
  • Department of Basic Medical Sciences, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • Department of Biosciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • Quaid-e-Azam University, Islamabad, Pakistan.
  • Deparmatment of Pharmaceutical Chemistry, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
  • Department of Orthopedics, PLA Naval Medical Center, Shanghai, China.

ORCID-Profile: Halima Qadir, Faiza Naseer, Madiha Kanwal, Bei Zhuang

Zitieren

APA

Li, J., Anjum, I., Qadir, H., Naseer, F., Arif, M., Riaz, M., Gul, R., Kanwal, M., & Zhuang, B. (2026). Anti‐Arthritic Potential of Pyrazoline Derivative Against Complete Freund's Adjuvant Induced Arthritis in Rats. Journal of Cellular and Molecular Medicine, 30(4). https://doi.org/10.1111/jcmm.71030

Vancouver

Li J, Anjum I, Qadir H, Naseer F, Arif M, Riaz M, et al. Anti‐Arthritic Potential of Pyrazoline Derivative Against Complete Freund's Adjuvant Induced Arthritis in Rats. Journal of Cellular and Molecular Medicine. 2026;30(4). doi:10.1111/jcmm.71030

BibTeX
@article{Li2026,
  author = {Li, Jian and Anjum, Irfan and Qadir, Halima and Naseer, Faiza and Arif, Mehreen and Riaz, Muhammad and Gul, Rabia and Kanwal, Madiha and Zhuang, Bei},
  title = {Anti‐Arthritic Potential of Pyrazoline Derivative Against Complete Freund's Adjuvant Induced Arthritis in Rats},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {4},
  doi = {10.1111/jcmm.71030}
}
Kostenlos starten →